Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 60 Results Clear All
The new study paves the way toward more effective cancer immunotherapies
News Release Cancer Genomic Immunology Marson Lab
Cancer Research Institute—The Cancer Research Institute recently announced its newest cohort of Scientists Taking Risks (STAR) funding for high risk/high reward research in tumor biology. Of the six recipients, three are core members of the Gladstone-UCSF Institute of Genomic Immunology: Kole Roybal, Ansuman Satpathy, and Matthew Spitzer.
Awards Gladstone Experts Genomic Immunology
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancer
News Release Research (Publication) Cancer Genomic Immunology
Fierce Biotech—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues at UC San Francisco and the Salk Institute for Biological Studies, recently showed that obese mice with atopic dermatitis had an altered immune response that made them refractory to anti-inflammatory treatment. Fierce Biotech discusses the implications of this finding for the development of drugs against inflammation and asthma.
Gladstone Experts Genomic Immunology Marson Lab Disease Models
A new catalog to help better understand how HIV hijacks human cells
Research (Publication) HIV/AIDS Data Science and Biotechnology Genomic Immunology Virology Krogan Lab Marson Lab
STAT News—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, describes new research from his group showing that the immune response in a mouse model of atopic dermatitis is altered by obesity. This difference rendered first-line therapies ineffective in mice, indicating that treatments for inflammatory disorders may need to be tailored to work in individual patients, depending on their metabolic state.
Gladstone Experts Genomic Immunology Marson Lab Disease Models Metabolism
Researchers have discovered why immune treatments for allergies and asthma might not be as effective in obese mice and humans
News Release Research (Publication) Genomic Immunology Marson Lab
Researchers adapt a variation of the CRISPR-Cas9 system to activate genes in human immune cells and study the consequences
News Release Research (Publication) Genomic Immunology Marson Lab CRISPR/Gene Editing
Watch recordings from the Gladstone-UCSF Institute of Genomic Immunology Symposium
Gladstone Experts Genomic Immunology Marson Lab Pelka Lab Genomics
Nautilus—In the ongoing war on cancer, some scientists are taking a new approach—turning on the body’s own self defense system. Assistant Investigator Karin Pelka describes her team’s efforts to train the immune system to recognize and fight tumors.
Gladstone Experts Genomic Immunology Pelka Lab
Karin Pelka will leverage the innate immune system to find new ways to tackle cancer and other diseases
Institutional News News Release Profile Genomic Immunology Pelka Lab
Gladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytes
News Release Research (Publication) Data Science and Biotechnology Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
Researchers developed a new technique that lets them map variation across the cells in a tissue or tumor
News Release Research (Publication) Genomic Immunology Marson Lab Single Cell
Watch the presentations from the inaugural Gladstone-UCSF Institute of Genomic Immunology Symposium
Genomic Immunology Marson Lab Genomics
Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab’s recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.
Gladstone Experts Autoimmune Diseases Genomic Immunology Marson Lab
